0001863964-21-000001.txt : 20210524
0001863964-21-000001.hdr.sgml : 20210524
20210524130821
ACCESSION NUMBER: 0001863964-21-000001
CONFORMED SUBMISSION TYPE: D
PUBLIC DOCUMENT COUNT: 1
ITEM INFORMATION: 06b
FILED AS OF DATE: 20210524
DATE AS OF CHANGE: 20210524
EFFECTIVENESS DATE: 20210524
FILER:
COMPANY DATA:
COMPANY CONFORMED NAME: Bioverge Funds, HepaTx I, LLC
CENTRAL INDEX KEY: 0001863964
IRS NUMBER: 854294963
STATE OF INCORPORATION: ID
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: D
SEC ACT: 1933 Act
SEC FILE NUMBER: 021-400369
FILM NUMBER: 21952808
BUSINESS ADDRESS:
STREET 1: 222 N 13TH ST.
CITY: BOISE
STATE: ID
ZIP: 83702
BUSINESS PHONE: 2086961262
MAIL ADDRESS:
STREET 1: C/O LOON CREEK CAPITAL
STREET 2: PO BOX 6088
CITY: BOISE
STATE: ID
ZIP: 83707
D
1
primary_doc.xml
X0708
D
LIVE
0001863964
Bioverge Funds, HepaTx I, LLC
222 N 13TH ST.
BOISE
ID
IDAHO
83702
2086961262
IDAHO
None
None
Limited Liability Company
true
2020
Neil
-
Bioverge Funds Management, LLC - Littman
237 Kearny Street #9171
San Francisco
CA
CALIFORNIA
94108
Executive Officer
Investing
Not Applicable
- 06b
false
2021-05-20
false
true
false
1500
Bioverge Funds Management, LLC
None
None
None
237 Kearny Street #9171
San Francisco
CA
CALIFORNIA
94108
CA
CALIFORNIA
false
150000
128436
21564
false
10
0
0
5000
true
false
Bioverge Funds, HepaTx I, LLC
Neil J Littman
Neil J Littman
Manager of the Issuer?s Manager
2021-05-24